Owens & Minor (NYSE:OMI) & Senestech (NASDAQ:SNES) Head-To-Head Analysis

Senestech (NASDAQ:SNES) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Insider & Institutional Ownership

5.2% of Senestech shares are owned by institutional investors. Comparatively, 98.0% of Owens & Minor shares are owned by institutional investors. 5.3% of Senestech shares are owned by company insiders. Comparatively, 3.7% of Owens & Minor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Senestech and Owens & Minor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senestech	-253.54%	-98.35%	-73.17%
Owens & Minor	-19.99%	95.57%	2.30%

Risk & Volatility

Senestech has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for Senestech and Owens & Minor, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1	1	0	1	2.33
Owens & Minor	4	0	3	1	2.13

Owens & Minor has a consensus target price of $6.35, indicating a potential upside of 124.78%. Given Owens & Minor’s higher probable upside, analysts plainly believe Owens & Minor is more favorable than Senestech.

Valuation & Earnings

This table compares Senestech and Owens & Minor”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senestech	$1.86 million	6.54	-$6.18 million	($3.65)	-0.64
Owens & Minor	$10.70 billion	0.02	-$362.69 million	($17.40)	-0.16

Senestech has higher earnings, but lower revenue than Owens & Minor. Senestech is trading at a lower price-to-earnings ratio than Owens & Minor, indicating that it is currently the more affordable of the two stocks.

Summary

Owens & Minor beats Senestech on 9 of the 14 factors compared between the two stocks.

About Senestech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

About Owens & Minor

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.